Article: Dyslipidemia and Superoxide Dismutase Activity in Children with Down Syndrome
Abstract:
Introduction: Down Syndrome (trisomy 21) provides an interesting natural model to study atherosclerosis, since these individuals appear to be protected from plaque formation.
Methodology: We assessed the lipid levels, and superoxide dismutase (SOD) activity in 32 clinically diagnosed children of Down syndrome and 34 children matched for age and sex as controls.
Results: SOD activity was found to be significantly higher (p=0.004) in children with Down Syndrome (mean=313.7 IU/ml) than in controls (mean140.2 IU/ ml). Significantly higher levels of serum triglyceride (154.7 mg/dl) and VLDL (33.9 mg/dl) were observed in Down Syndrome as compared to healthy controls (119.6 mg/dl and 23.9 mg/dl respectively; p<0.05 for each). However, the two groups did not show any significant difference in levels of serum HDL-C, LDL-C.
Conclusion: The raised antioxidant activity of SOD, because of over expression of genes situated non chromosome 21, probably offers some protection against the development of atherosclerosis despite the occurrence of dyslipidemia.
P Goyal
Department of Biochemistry, Shreemati Sucheta Kripalini Hospital, Lady Hardinge Medical College, New Delhi
R Singh
Department of Biochemistry, Shreemati Sucheta Kripalini Hospital, Lady Hardinge Medical College, New Delhi
A Yadav
Department of Biochemistry, Shreemati Sucheta Kripalini Hospital, Lady Hardinge Medical College, New Delhi
AK Dutta
Department of Paediatrics, Kalawati Saran Children’s Hospital, Lady Hardinge Medical College, New Delhi
J Bhattacharjee
Department of Paediatrics, Kalawati Saran Children’s Hospital, Lady Hardinge Medical College, New Delhi
Keywords
Chromosome 21, Down Syndrome, Trisomy 21, Superoxide dismutase
Identifier
https://doi.org/10.3126/jnps.v30i3.3919
Citation
Collections